Low concentration of topical cyclosporin A for severe alopecia areata

P. D. Pigatto, M. M. Montalbano, R. Cirillo, N. Mozzanica, G. F. Altomare, A. F. Finzi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.

Original languageEnglish
Pages (from-to)377-382
Number of pages6
JournalAnnali Italiani di Dermatologia Clinica e Sperimentale
Volume42
Issue number4
Publication statusPublished - 1988

Fingerprint

Alopecia Areata
Cyclosporine
Placebos
Scalp
Therapeutics
Recurrence

ASJC Scopus subject areas

  • Dermatology

Cite this

Low concentration of topical cyclosporin A for severe alopecia areata. / Pigatto, P. D.; Montalbano, M. M.; Cirillo, R.; Mozzanica, N.; Altomare, G. F.; Finzi, A. F.

In: Annali Italiani di Dermatologia Clinica e Sperimentale, Vol. 42, No. 4, 1988, p. 377-382.

Research output: Contribution to journalArticle

Pigatto, P. D. ; Montalbano, M. M. ; Cirillo, R. ; Mozzanica, N. ; Altomare, G. F. ; Finzi, A. F. / Low concentration of topical cyclosporin A for severe alopecia areata. In: Annali Italiani di Dermatologia Clinica e Sperimentale. 1988 ; Vol. 42, No. 4. pp. 377-382.
@article{285b1a051ebb4cf688808c4dfe745b88,
title = "Low concentration of topical cyclosporin A for severe alopecia areata",
abstract = "The results of a trial on 59 patients with severe alopecia areata involving more than 30{\%} of the scalp are reported. Topical 0.2{\%} cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.",
author = "Pigatto, {P. D.} and Montalbano, {M. M.} and R. Cirillo and N. Mozzanica and Altomare, {G. F.} and Finzi, {A. F.}",
year = "1988",
language = "English",
volume = "42",
pages = "377--382",
journal = "Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale",
issn = "1592-6826",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "4",

}

TY - JOUR

T1 - Low concentration of topical cyclosporin A for severe alopecia areata

AU - Pigatto, P. D.

AU - Montalbano, M. M.

AU - Cirillo, R.

AU - Mozzanica, N.

AU - Altomare, G. F.

AU - Finzi, A. F.

PY - 1988

Y1 - 1988

N2 - The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.

AB - The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.

UR - http://www.scopus.com/inward/record.url?scp=0024246043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024246043&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 377

EP - 382

JO - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

JF - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

SN - 1592-6826

IS - 4

ER -